Urology News and Research

Latest Urology News and Research

Key recommendations on genetic testing of men for prostate cancer

Prostate cancer is a leading cause of death from cancer in the US and especially in the Philadelphia region. Consistently, Philadelphia has outpaced the state of PA and the nation in diagnoses and death from prostate cancer.

10 Jun 2020

Gleason grade group 5 prostate cancer can be divided into subtypes with distinct differences

Researchers at the UCLA Jonsson Comprehensive Cancer Center analyzed gene-expression patterns in the most aggressive prostate cancer grade group -- known as Gleason grade group 5 -- and found that this grade of cancer can actually be subdivided into four subtypes with distinct differences.

4 Jun 2020

Nox4 protein can be used as a marker to predict untreatable kidney cancer

A team of researchers from The University of Texas Health Science Center at San Antonio confirmed the role of a certain protein in the development of high-grade kidney cancer.

4 Jun 2020

University of Freiburg receives 30 million euros for excellent research

The German Research Foundation has approved a new proposal for a collaborative research center under the leadership of the Institute for Experimental Cardiovascular Medicine at the University Heart Centre Freiburg · Bad Krozingen.

30 May 2020

Clinical trial shows anti-tumor responses in metastatic castration-resistant prostate cancer patients

The preliminary results of a Phase I clinical trial conducted by researchers at the Yale Cancer Center have shown that ARV-110, an androgen receptor PROTAC protein degrader, demonstrates clinical evidence of anti-tumor responses in patients with metastatic castration-resistant prostate cancer (mCRPC) who have failed prior therapy.

29 May 2020

Study reports COVID-19 case-fatality trends among people with IDD

A new study published recently in ScienceDirect by researchers from Syracuse University and SUNY Upstate Medical University shows that people with intellectual and developmental disabilities (IDD) are more likely to die from COVID-19 than those without IDD.

28 May 2020

Simple urine-testing method for people with kidney stones offers results in 30 minutes

An improved urine-testing system for people suffering from kidney stones inspired by nature and proposed by researchers from Penn State and Stanford University may enable patients to receive results within 30 minutes instead of the current turnaround time of a week or more.

27 May 2020

Stand Up To Cancer hails FDA approval of new treatment option for aggressive prostate cancer

A recent FDA approval supported by Stand Up To Cancer research provides a new treatment option for patients with an aggressive form of prostate cancer.

27 May 2020

Researchers identify genetic mechanisms that produce radioresistance in cancer cells

Cancer stem cells are a cell type that was previously little known. They are resistant to irradiation and prevent the effective treatment of many types of cancer. A research group from Innsbruck has now identified two genetic mechanisms that produce this radioresistance.

26 May 2020

Recommendations for treating bladder cancer during COVID-19 pandemic

Bladder cancer is associated with significant illness and mortality, particularly if treatment is delayed.

22 May 2020

New technique reveals potentially treatable mutations in subset of prostate cancer patients

Prostate cancer patients who do not respond well to PSMA-targeted therapy often have potentially treatable mutations in their DNA damage-repair genes, according to research published in the May issue of The Journal of Nuclear Medicine.

20 May 2020

UCLA-led clinical trial to assess if hormone suppresser will reduce COVID-19 severity in men

UCLA researchers have launched a new clinical trial that uses a hormone suppresser commonly used to treat men with prostate cancer to help improve clinical outcomes for men infected with COVID-19.

15 May 2020

Novel radiotracer is an effective option for staging of prostate cancer

The novel radiopharmaceutical 18F-PSMA-1007 is both effective and readily available for detecting malignant prostate cancer lesions, according to research published in the April issue of The Journal of Nuclear Medicine.

11 May 2020

Researchers develop guide to help organizations introduce telemedicine as an alternative option

Stay-at-home orders caught many medical practices and health care systems off guard, leaving them ill-equipped to rapidly adopt an efficient telemedicine platform so they could keep providing time-sensitive care to non-COVID-19 patients.

4 May 2020

Innovative approach offers kidney-sparing treatment option for upper tract urothelial cancer

Treatment of low-grade upper tract urothelial cancer usually involves radical surgery to remove the kidney and ureter, highlighting the need for improved treatments.

30 Apr 2020

Researchers recreate how toxins from smoking cause DNA damage

Researchers from the University of York have recreated how toxins from smoking cause unique patterns of DNA damage.

28 Apr 2020

GRAIL to present new data at the American Association for Cancer Research (AACR) annual meeting

GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting I.

From GRAIL, Inc. 28 Apr 2020

Urology News and Research

Latest Urology News and Research

Key recommendations on genetic testing of men for prostate cancer

Gleason grade group 5 prostate cancer can be divided into subtypes with distinct differences

Nox4 protein can be used as a marker to predict untreatable kidney cancer

University of Freiburg receives 30 million euros for excellent research

Clinical trial shows anti-tumor responses in metastatic castration-resistant prostate cancer patients

Study reports COVID-19 case-fatality trends among people with IDD

Simple urine-testing method for people with kidney stones offers results in 30 minutes

Stand Up To Cancer hails FDA approval of new treatment option for aggressive prostate cancer

Researchers identify genetic mechanisms that produce radioresistance in cancer cells

Recommendations for treating bladder cancer during COVID-19 pandemic

New technique reveals potentially treatable mutations in subset of prostate cancer patients

UCLA-led clinical trial to assess if hormone suppresser will reduce COVID-19 severity in men

Novel radiotracer is an effective option for staging of prostate cancer

Researchers develop guide to help organizations introduce telemedicine as an alternative option

Innovative approach offers kidney-sparing treatment option for upper tract urothelial cancer

Researchers recreate how toxins from smoking cause DNA damage

GRAIL to present new data at the American Association for Cancer Research (AACR) annual meeting

COVID-19 unlikely to be transmitted through semen, study shows

Study finds NCCN Guidelines for Patients listed among the most trustworthy online resources

A 'toolbox' for biomarker discovery of urological cancers

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Urology News and Research

Latest Urology News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in